Commonwealth IME Competitors

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2020 revenues of $9.44 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

Healthesystems is a specialty provider of innovative medical cost management solutions for the workers’ compensation industry. Our diverse suite of services includes a leading Pharmacy Benefit Management (PBM) program and Clinical Review Services as well as a revolutionary Ancillary Benefits Management (ABM) program for managing and adjudicating ancillary medical services. Leveraging powerful technology, clinical expertise and enhanced workflow automation tools, we provide clients with flexible programs that reduce the total cost of medical care while increasing the quality of care for injured workers. We are committed to developing new ideas to help our clients navigate the complex workers’ compensation industry while achieving measurable results such as improved pharmacy transaction efficiency, network penetration and drug utilization. Our services are tailored to each of our client’s needs to increase value and maximize results. Services include: A leading Pharmacy Benefit Management (PBM) program Comprehensive Clinical Review Services An unrivaled Ancillary Benefits Management (ABM) program Trending and Data Analytics tools Innovative Technology Solutions and Systems Integration Services To sign up to receive our news and views in workers' comp visit: http://workerscomprehensive.healthesystems.com/index.php For the latest edition of our Rx Informer industry journal visit: www.healthesystems.com/rxinformer

ExamOne has provided a robust portfolio of laboratory, paramedical and data solutions since 1972, giving it a great deal of understanding about the needs of life insurance and health and life sciences clients and the consumers they serve. #lifeinsurance #healthandlifesciences Laboratory testing was part of the company’s original services and its role has expanded to include paramedical exams, fraud detection, electronic data collection, and gathering attending physician statements and motor vehicle records. ExamOne has also expanded into helping individuals learn about their own health through its Inside Look™ and Blueprint for Wellness® products.